Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The central and gut–brain stress-related pathways represent a complex, bidirectional communication network that integrates the central nervous system (CNS) with the enteric nervous system (ENS) and the gastrointestinal tract (Carabotti et al., 2015, Annals of Gastroenterology). This system utilizes neural, endocrine, and immune signaling to maintain homeostasis and coordinate the body's response to psychological and physical stressors. Key mediators include the hypothalamic-pituitary-adrenal (HPA) axis and signaling molecules like corticotropin-releasing factor (CRF), which regulate gut motility, permeability, and immune function (Taché et al., 2018, Frontiers in Systems Neuroscience). Dysregulation of these pathways is a hallmark of functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), and is increasingly linked to psychiatric conditions like anxiety and depression (Konturek et al., 2011, Journal of Physiology and Pharmacology). While the pathway itself is not a single molecular target, it contains numerous specific targets—including CRF receptors and serotonin transporters—that are the focus of therapeutic intervention to treat stress-related disorders. Understanding these pathways is crucial for developing holistic treatments that address the interplay between mental health and digestive function.
Modulation of the bidirectional communication between the central nervous system and the enteric nervous system via the HPA axis, autonomic nervous system, and neuro-immune signaling pathways (Carabotti et al., 2015, Annals of Gastroenterology).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central and gut–brain stress-related pathways (GBA) (GBA).